A Degarelix Trial in Patients With Prostate Cancer

Clinical trial NCT01242748 · TERMINATED

Trial details

NCT number: NCT01242748
Sponsor: Ferring Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-10-01
Primary completion: 2011-12-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.